NDC11 79378021030
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 79378-0210-30 | 79378-0210 |
| 79378-210-30 | 79378-210 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Livmarli | MARALIXIBAT CHLORIDE | Mirum Pharmaceuticals Inc. | 64000394-1ef6-4e76-8ba8-11f25ba1b167 | 2025-04-10 | Warnings, Adverse reactions | 79378-210-30 79378-210 79378021030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.